SOLDOVIERI, Maria Virginia
 Distribuzione geografica
Continente #
EU - Europa 3.888
NA - Nord America 3.840
AS - Asia 1.142
SA - Sud America 306
AF - Africa 129
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 10
AN - Antartide 1
Totale 9.329
Nazione #
US - Stati Uniti d'America 3.756
RU - Federazione Russa 1.946
IE - Irlanda 630
SG - Singapore 471
CN - Cina 315
BR - Brasile 258
IT - Italia 184
UA - Ucraina 169
FI - Finlandia 160
AT - Austria 152
DE - Germania 147
SE - Svezia 135
GB - Regno Unito 132
CI - Costa d'Avorio 98
BE - Belgio 86
VN - Vietnam 80
IN - India 61
CA - Canada 52
HK - Hong Kong 51
FR - Francia 40
JP - Giappone 37
PL - Polonia 31
MX - Messico 22
AR - Argentina 18
ES - Italia 18
NL - Olanda 17
ZA - Sudafrica 17
BD - Bangladesh 16
ID - Indonesia 14
LT - Lituania 13
TR - Turchia 13
IQ - Iraq 12
IR - Iran 12
AU - Australia 9
IL - Israele 9
CL - Cile 8
EU - Europa 8
EC - Ecuador 7
JO - Giordania 7
CO - Colombia 6
JM - Giamaica 5
KZ - Kazakistan 5
MY - Malesia 5
PY - Paraguay 5
RO - Romania 5
SA - Arabia Saudita 5
TN - Tunisia 5
KR - Corea 4
MD - Moldavia 4
NZ - Nuova Zelanda 4
PK - Pakistan 4
AE - Emirati Arabi Uniti 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
GR - Grecia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AZ - Azerbaigian 2
DK - Danimarca 2
DZ - Algeria 2
KG - Kirghizistan 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
MA - Marocco 2
PH - Filippine 2
VE - Venezuela 2
AO - Angola 1
AQ - Antartide 1
BG - Bulgaria 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
GE - Georgia 1
GM - Gambi 1
GT - Guatemala 1
KE - Kenya 1
KW - Kuwait 1
ML - Mali 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TH - Thailandia 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 9.329
Città #
Dallas 883
Moscow 638
Dublin 627
Chandler 459
Jacksonville 386
Singapore 229
Beijing 169
Ann Arbor 163
Vienna 147
Ashburn 134
New York 130
Wilmington 127
Helsinki 117
Abidjan 98
Woodbridge 91
Brussels 86
San Mateo 73
Los Angeles 68
Boardman 67
Princeton 57
Rome 52
Hong Kong 51
The Dalles 44
Houston 40
São Paulo 33
Tokyo 28
Molise 27
Ho Chi Minh City 26
Columbus 25
Dearborn 24
London 23
Chennai 22
Warsaw 22
Stockholm 19
Toronto 18
Poplar 17
Montreal 16
Falls Church 15
Redwood City 15
San Francisco 15
Orem 14
Brooklyn 13
Frankfurt am Main 13
Johannesburg 13
Munich 13
Napoli 13
Phoenix 13
Boston 12
Hanoi 12
Hefei 12
Jakarta 12
Nanjing 12
Atlanta 10
Da Nang 10
Kunming 10
Denver 9
Falkenstein 9
Mountain View 9
Naples 9
Norwalk 9
Santa Clara 9
Auburn Hills 8
Augusta 8
Chicago 8
Mumbai 8
Amman 7
Amsterdam 7
Ankara 7
Mexico City 7
Querétaro 7
San Jose 7
Brasília 6
Clearwater 6
Council Bluffs 6
Fortaleza 6
Milan 6
Seattle 6
Baghdad 5
Calgary 5
Charlotte 5
Curitiba 5
Manchester 5
Nuremberg 5
Ottawa 5
Paris 5
Pune 5
Quito 5
Shenyang 5
Turku 5
Wroclaw 5
Wuhan 5
Zhengzhou 5
Belo Horizonte 4
Buenos Aires 4
Campo Grande 4
City of London 4
Leawood 4
Porto Alegre 4
Rio de Janeiro 4
Roseto Degli Abruzzi 4
Totale 5.734
Nome #
Activation and Desensitization of Trpv1 Channels in Sensory Neurons by the Peroxisome Proliferator-Activated Receptor α Agonist Palmitoylethanolamide 264
Activation of Kv7 potassium channels inhibits intracellular Ca2+ increases triggered by TRPV1-mediated pain-inducing stimuli in F11 immortalized sensory neurons 246
Atypical gating of M-type potassium channels conferred by mutations in uncharged residues in the S-4 region of KCNQ2 causing benign familial neonatal convulsions 216
Epilepsy-causing mutations in kv7.2 c-terminus affect binding and functional modulation by calmodulin. 200
Autism and developmental disability caused by KCNQ3 gain-of-function variants 195
Pharmacological Targeting Of Neuronal Kv7.2/3 Channels: A Focus On Chemotypes And Receptor Sites 192
Characterization of two de novo KCNT1 mutations in children with malignant migrating partial seizures in infancy 187
Molecular pathophysiology and pharmacology of the voltage-sensing module of neuronal ion channels 186
A novel KCNQ2 K+ channel mutation in benign neonatal convulsions and centrotemporal spikes 185
Epileptic encephalopathy in a patientwith a novel variant in the Kv7.2 S2 transmembrane segment: Clinical, genetic, and functional features 182
Effects of natural and synthetic isothiocyanate-based H2S-releasers against chemotherapy-induced neuropathic pain: Role of Kv7 potassium channels 182
Expression and function of Kv7.4 channels in Rat cardiac mitochondria: possible targets for cardioprotection 180
A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy 178
Early-Onset Epileptic Encephalopathy Caused by Gain-of-Function Mutations in the Voltage Sensor of Kv7.2 and Kv7.3 Potassium Channel Subunits. 177
A novel mutation in KCNQ2 associated with BFNC, drug resistant epilepsy, and mental retardation 177
De novo gain-of-function variants in KCNT2 as a novel cause of developmental and epileptic encephalopathy 175
Early-onset epileptic encephalopathy caused by a reduced sensitivity of Kv7.2 potassium channels to phosphatidylinositol 4,5-bisphosphate 173
The occurrence of a Kv7.4 potassium channel in neuronal mitochondria 173
Differential Regulation of PI(4,5)P2Sensitivity of Kv7.2 and Kv7.3 Channels by Calmodulin 170
A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability. 170
Early Treatment with Quinidine in 2 Patients with Epilepsy of Infancy with Migrating Focal Seizures (EIMFS) Due to Gain-of-Function KCNT1 Mutations: Functional Studies, Clinical Responses, and Critical Issues for Personalized Therapy 167
Cardiotoxic effects of antihistamines: From basics to clinics (... and back) 161
Calcium cytotoxicity sensitizes prostate cancer cells to standard-of-care treatments for locally advanced tumors 161
Addressing the use of PDIF-CN(2) molecules in the development of n-type organic field-effect transistors for biosensing applications 159
Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant 159
Identification of a Potent Tryptophan-Based TRPM8 Antagonist with in Vivo Analgesic Activity 157
A new Italian FHM2 family: Clinical aspects and functional analysis of the disease-associated mutation 150
Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine 146
Molecular pharmacology and therapeutic potential of neuronal Kv7-modulating drugs 144
β-Adrenergic response is counteracted by extremely-low-frequency pulsed electromagnetic fields in beating cardiomyocytes 142
A Novel Kv7.3 Variant in the Voltage-Sensing S4 Segment in a Family With Benign Neonatal Epilepsy: Functional Characterization and in vitro Rescue by β-Hydroxybutyrate 142
Neutralization of a unique, negatively-charged residue in the voltage sensor of K(V)7.2 subunits in a sporadic case of benign familial neonatal seizures 140
Critical role of large-conductance calcium- and voltage-activated potassium channels in leptin-induced neuroprotection of N-methyl-d-aspartate-exposed cortical neurons. 140
Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions 138
Expression, Localization, and Pharmacological Role of K(v)7 Potassium Channels in Skeletal Muscle Proliferation, Differentiation, and Survival after Myotoxic Insults 136
CORRELATING THE CLINICAL AND GENETIC FEATURES OF BENIGN FAMILIAL NEONATAL SEIZURES (BFNS) WITH THE FUNCTIONAL CONSEQUENCES OF THE UNDERLYING MUTATIONS 136
Tryptamine-Based Derivatives as Transient Receptor Potential Melastatin Type 8 (TRPM8) Channel Modulators 134
Kv7.3 Compound Heterozygous Variants in Early Onset Encephalopathy Reveal Additive Contribution of C-Terminal Residues to PIP2-Dependent K+Channel Gating 132
Gabapentin treatment in a patient with KCNQ2 developmental epileptic encephalopathy 128
Erratum to: Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 127
Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A 125
Kv7.4 channels regulate potassium permeability in neuronal mitochondria 125
A novel KCNC1 gain-of-function variant causing developmental and epileptic encephalopathy: "Precision medicine" approach with fluoxetine 124
Driving with no brakes: molecular pathophysiology of kv7 potassium channels 122
Genotype-phenotype correlations in neonatal epilepsies caused by mutations in the voltage sensor of K(v)7.2 potassium channel subunits 121
Epileptic channelopathies caused by neuronal Kv7 (KCNQ) channel dysfunction 116
De novo variants in KCNA3 cause developmental and epileptic encephalopathy 116
KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism 115
Gain of function due to increased opening probability by two KCNQ5 pore variants causing developmental and epileptic encephalopathy 113
Functional Characterization of Two Variants at the Intron 6-Exon 7 Boundary of the KCNQ2 Potassium Channel Gene Causing Distinct Epileptic Phenotypes 112
Isoxazole derivatives as potent transient receptor potential melastatin type 8 (TRPM8) agonists. 111
Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility 110
The Voltage-Sensing Domain of K(v)7.2 Channels as a Molecular Target for Epilepsy-Causing Mutations and Anticonvulsants 108
Case report: Marked electroclinical improvement by fluoxetine treatment in a patient with KCNT1-related drug-resistant focal epilepsy 106
Fluoxetine Treatment in Epilepsy of Infancy with Migrating Focal Seizures Due to KCNT1 Variants: An Open Label Study. 102
Lysinuric protein intolerance: identification and functional analysis of mutations of the SLC7A7 gene 102
Functional and biochemical interaction between PPARα receptors and TRPV1 channels: Potential role in PPARα agonists-mediated analgesia. 101
The ever changing moods of calmodulin: how structural plasticity entails transductional adaptability. 100
Distinct epilepsy phenotypes and response to drugs in KCNA1 gain- and loss-of function variants 97
Functional analysis of novel KCNQ2 and KCNQ3 gene variants found in a large pedigree with benign familial neonatal convulsions (BFNC) 90
Gating consequences of charge neutralization of arginine residues in the S-4 segment of K(v)7.2, an epilepsy-linked K+ channel subunit 88
Synthesis and Pharmacological Characterization of Conformationally Restricted Retigabine Analogues as Novel Neuronal Kv7 Channel Activators 87
In Silico Assisted Identification, Synthesis, and In Vitro Pharmacological Characterization of Potent and Selective Blockers of the Epilepsy-Associated KCNT1 Channel 82
KCNT2-Related Disorders: Phenotypes, Functional, and Pharmacological Properties 77
Towards the realization of label-free biosensors through impedance spectroscopy integrated with IDES technology 75
The long and winding road to personalized medicine in KCNMA1-linked channelopathies revealed by novel variants associated with the Liang-Wang syndrome 70
Pharmacological approaches in drug-resistant pediatric epilepsies caused by pathogenic variants in potassium channel genes. 66
null 58
Totale 9.526
Categoria #
all - tutte 40.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.488


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021279 0 0 0 0 0 42 69 3 62 10 79 14
2021/2022402 13 65 4 13 42 44 12 35 75 43 26 30
2022/20231.807 225 80 30 181 133 169 11 79 780 59 42 18
2023/2024357 72 40 16 7 8 95 10 17 12 11 10 59
2024/20251.239 111 49 147 51 252 56 72 66 106 28 122 179
2025/20263.927 178 522 590 376 1.427 834 0 0 0 0 0 0
Totale 9.526